Related Experiment Video
Updated: Feb 14, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
Stimuli-responsive chitosan-based nanocarriers for cancer therapy
Marziyeh Fathi1, Parham Sahandi Zangabad1, Sima Majidi2
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Chitosan (CS)-based stimuli-responsive nanocarriers offer advanced drug delivery systems (DDSs) for targeted cancer therapy. These smart nanosystems enable on-demand drug release, improving treatment efficacy and diagnosis.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Stimuli-responsive nanocarriers provide targeted drug delivery and on-demand release capabilities.
- Chitosan (CS)-based drug delivery systems (DDSs) exhibit excellent biocompatibility and biodegradability.
Purpose of the Study:
- To review recent advancements in stimuli-responsive nanocarriers, focusing on CS-based nanosystems.
- To discuss the applications of these CS-based nanosystems in cancer therapy and diagnosis.
Main Methods:
- Literature survey of stimuli-responsive nanocarriers.
- Analysis of recent developments in CS-based nanosystems.
- Review of applications in cancer treatment and diagnostics.
Main Results:
- CS-based DDSs are ideal smart, multifunctional systems due to biocompatibility, biodegradability, and ease of functionalization.
- These nanocarriers respond to endogenous (pH, enzymes) or exogenous (light, temperature) stimuli for controlled release.
- Dual-responsive nanocarriers offer enhanced efficiency for drug delivery.
Conclusions:
- CS-based stimuli-responsive multifunctional nanosystems show significant potential for targeted anticancer drug delivery.
- These systems enable precise, on-demand release of therapeutic agents, improving cancer treatment outcomes.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

